Compliance Rate
Compliance Rate
0.0%
Compliant submissions
0
Incompliant submissions
1
Total trials
1
My Organizations' Clinical Trials
Showing 500 of 1949 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/20/21
End: 01/09/23
Due: 01/09/24
Phase: N/A
Priority: Normal
Start: 06/30/23
End: 08/23/24
Due: 08/23/25
Phase: N/A
Priority: Normal
Start: 03/08/21
End: 01/15/25
Due: 01/15/26
Phase: N/A
Priority: Normal
Start: 08/04/25
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 12/01/25
End: 12/01/26
Due: 12/01/27
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 10/04/19
Due: 10/04/20
Phase: N/A
Priority: Normal
Start: 02/29/08
End: 05/31/09
Due: 05/31/10
Phase: N/A
Priority: Normal
Start: 07/07/25
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 08/15/19
End: 07/19/23
Due: 07/19/24
Phase: N/A
Priority: Normal
Start: 11/30/14
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 04/30/07
End: 11/30/08
Due: 11/30/09
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 01/31/04
End: 12/31/05
Due: 12/31/06
Phase: N/A
Priority: Normal
Start: 03/06/18
End: 10/19/21
Due: 10/19/22
Phase: N/A
Priority: Normal
Start: 05/24/21
End: 11/13/23
Due: 11/13/24
Phase: N/A
Priority: Normal
Start: 06/16/17
End: 08/27/18
Due: 08/27/19
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 06/14/18
Due: 06/14/19
Phase: N/A
Priority: Normal
Start: 06/30/07
End: 01/31/10
Due: 01/31/11
Phase: N/A
Priority: Normal
Start: 05/31/09
End: 08/31/10
Due: 08/31/11
Phase: N/A
Priority: Normal
Start: 12/10/19
End: 06/03/20
Due: 06/03/21
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 08/31/14
Due: 08/31/15
A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR Mutations
Phase: N/A
Priority: Normal
Start: 06/30/18
End: 10/12/22
Due: 10/12/23
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 05/31/16
Due: 05/31/17
Phase: N/A
Priority: Normal
Start: 08/31/13
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 10/24/22
End: 07/07/23
Due: 07/07/24